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Exposure to environmental and occupational chemicals can result in human disease which 
may be driven by genotoxicity and epigenetic alterations. In addition, genetic variants and 
sex-specific differences in epigenetic modifications and DNA damage may also influence 
chemical-induced adverse health effects. Our overall objective is to investigate inter-
individual variability in epigenetic alterations and DNA damage in response to 1,3-
butadiene, a model genotoxic carcinogen and industrial toxicant. Although genotoxicity 
is an established mechanism of 1,3-butadiene carcinogenesis, epigenetic effects such as 
DNA methylation and histone modifications have also been reported.  Importantly, inter-
strain differences exist in both 1,3-butadiene-induced DNA damage and epigenetic effects 
in mice. Recent studies indicate that the variation in epigenetic alterations may be a key 
driver of the inter-individual susceptibility to 1,3-butadiene genotoxicity. First, we 
characterized inter-individual differences in 1,3-butadiene-induced DNA damage and 
epigenetic effects using a population-based model of Collaborative Cross mouse strains. 
We observed strain- and tissue-dependent variability of 1,3-butadiene-induced epigenetic 
alterations which may influence individual and organ susceptibility to carcinogenesis. 
Genetic mapping identified several candidate genes that may play a role in individual 
differences in global histone modifications. Second, we investigated sex-specific effects 
in response to 1,3-butadiene. Strain- and tissue-specific differences in DNA damage and 
global epigenetic alterations were detected. Third, we evaluated the expression of 
microRNA in order to better understand the mechanisms by which 1,3-butadiene alters 




expression profiles of microRNA. Furthermore, we identified microRNA as candidate 
master regulators of differential gene expression across strains and tissues. Overall, our 
work contributes to a better understanding of inter-individual variability in response to 
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CHAPTER I  
INTRODUCTION: GENETIC AND EPIGENETIC DETERMINANTS OF INTER-
INDIVIDUAL VARIABILITY IN RESPONSES TO TOXICANTS1 
 
1.1 Overview 
It is well established that genetic variability has a major impact on susceptibility to 
common diseases, responses to drugs and toxicants, and influences disease-related 
outcomes. The appreciation that epigenetic marks also vary across the population is 
growing with more data becoming available from studies in humans and model organisms. 
In addition, the links between genetic variability, toxicity outcomes and epigenetics are 
being actively explored. Recent studies demonstrate that gene-by-environment 
interactions involve both chromatin states and transcriptional regulation, and that 
epigenetics provides important mechanistic clues to connect expression-related 
quantitative trait loci (QTL) and disease outcomes. Furthermore, sex-specific differences 
in response to chemical exposure may also play a role in individual susceptibility to 
disease development. We propose that assessment of global epigenetic changes and levels 
of DNA adducts is necessary to sufficiently characterize epigenetic alterations and 







1.2 Genetic Variability 
Estimation of the degree of inter-individual variability in the population is a required step 
in assessing the human health hazard posed by environmental chemicals. Indeed, the 
National Academies report Science and Decisions 1 called for the need to better “account 
for differences among humans in cancer susceptibility other than from possible early-life 
susceptibility.” Recent advances in the ability to conduct genome-wide association studies 
(GWAS) that identify quantitative trait loci (QTL) have enabled identification of genetic 
variants associated with important diseases 2. It is clear that genetic variation influences 
the response of an individual to drugs and chemicals 3. The blossoming field of 
personalized medicine now brings GWAS-enabled understanding of basic biology into 
clinical practice to determine how the knowledge of genetic variation can make therapies 
safer and more effective by tailoring selection and dosing of drugs for an individual patient 
4.  
GWAS that characterize effects of environmental toxicants on humans are usually 
based on epidemiological data, not controlled exposures 5. This makes it a challenge to 
interpret findings from human cohorts exposed in the occupational or environmental 
settings. In addition, collection of tissues (with the exception of blood) from a wide variety 
of anatomical sites or developmental stages is not possible in humans that have been 
exposed to environmental toxicants. These limitations can be alleviated, at least partially, 
by the use of appropriate genetically-diverse laboratory animal-based model systems 6.  
 
3 
The mouse is a popular in vivo model for which genetic resources with publicly 
available genetic maps across dozens of strains are now available 7. Mouse populations, 
such as the Collaborative Cross 8, provide an excellent testing system for evaluation of 
complexities in toxicokinetics and toxicodynamics 6, 9-11. In the past decade, it has been 
demonstrated convincingly that genetic diversity in the mouse can be used to identify 
sensitive sub-populations using a mouse model of the human population approach 12-25. 
Most of the genetic variability among mouse strains has been focused on SNPs; however, 
variation in structure of DNA regions affecting DNA sequence length and/or orientation 
that includes deletions, insertions, copy-number gains, inversions, and transposable 
elements, may also underpin susceptibility traits 26. In addition, while inbred mouse strains 
are considered isogenic, intra-strain differences and their influence on experimental 
outcomes have been identified 27, 28. 
While advances in sequencing technologies, statistical genetics analysis methods 
and clinical trial designs have shown promise for the discovery of variants associated with 
drug response, interpretation of both human and mouse GWAS through identifying causal 
variants is a challenge, and the translation of the findings to the clinic and/or regulatory 
actions is slow. On the one hand, it remains difficult to interpret the outcomes of GWAS 
and validate genes underlying QTLs with certainty, due in part to not knowing which 
organs, tissues, and/or cell types any particular QTL is having a significant functional 
effect. On the other hand, the GWAS-driven attempts to disentangle treatment responders 
from non-responders via genetic predictors in pharmacogenetics studies have not been 





1.3 Environmental agents cause toxicity through epigenetic mechanisms  
Epigenetic reprogramming has been proposed as an integral part of the “genome 
instability” enabling characteristic of cancer cells 30 and it is well established that chemical 
carcinogens may affect the cellular epigenetic state 31. Changes in DNA methylation, 
histone/chromatin remodeling, and altered expression of miRNAs represent the most 
frequently reported toxicant-induced alterations of the epigenome 32. Because of the 
potential impact of these epigenotoxic effects on gene expression patterns and, 
consequently, on the toxicity phenotypes, epigenetic changes have been proposed as 
biomarkers of carcinogen exposure and effect 33, 34.  
One of the first examples of the linkages between environment, epigenetics and 
phenotypes were studies of in utero exposure to environmental agents that can also disrupt 
the epigenome. The agouti mouse model was used to demonstrate that environmental 
factors may affect the fetal epigenome 35. Using this mouse model, maternal exposure to 
the endocrine disruptor BPA causes loss of DNA methylation at key loci, resulting in a 
shift in coat color of offspring 36. Normal methylation patterns can then be restored with 
maternal dietary supplementation using methyl donors like folic acid. Evidence shows 
along with DNA methylation, variable histone modifications affect the inter-individual 
epigenetic variation of this metastable epiallele 37.  
Another prominent example of how environmental toxicants may have epigenetic 
effects are studies on the mechanism of carcinogenesis for metals 38. Arsenic, a ubiquitous 
 
5 
environmental contaminant, disrupts the normal epigenome transforming the epigenetic 
landscape to reflect that of a cancer cell 39. Exposure to metals like arsenic causes 
significant epigenetic modifications such as changes in global histone methylation levels 
40.  After exposure to arsenic compounds, human lung carcinoma A549 cells showed an 
increase in global levels of H3K4me3 and H3K9me2 41. Similarly, human peripheral blood 
nuclear cells extracted from subjects exposed to high levels of arsenic in water had an 
increase in H3K9me2 levels 42.  
Environmental contaminants can also alter gene expression by epigenetically 
reprogramming tissues. Neonatal BPA exposure increases H3K4me3 levels in promoters 
of genes associated with prostate cancer through activation of histone methyltransferase 
MLL1 43. Although there was no difference in basal expression of levels of BPA 
reprogrammed genes, once challenged with hormone treatment, there is enhanced gene-
specific transcription. It is thought the change in levels of H3K4me3 primes these genes 
for an enhanced response. Additionally, evidence suggests that BPA exposure during 
prostate development could epigenetically reprogram the expression of Scgb2a1 in the 
adult prostate 44.  
Epigenetic changes may be a consequence of DNA damage 45, or may be part of 
the non-genotoxic mechanisms of carcinogenesis 46. The interplay between chemical-
induced DNA damage response and transcription, DNA replication, and repair has only 
recently been linked to chromatin dynamics, especially to histone modifications and post-
repair chromatin restoration at the sites of DNA damage 47. For example, a local response 
to DNA double-stranded breaks gives rise to chromatin condensation which spreads at 
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least over several Kb from the damage sites and can induce epigenetic silencing of the 
nearby genes 48. In addition, it was shown that levels of the heterochromatin-associated 
histone modification H3K9me3 accounted for more than 40% of mutation rate variation, 
providing striking evidence that mutation rates in cancer genomes are related closely to 
chromatin organization 49. Besides that, DNA repair can cause local chromatin state 
transitions eventually resulting in prolonged inactivation of transcription via not yet fully 
established gene silencing mechanisms. Modulation of the epigenetic status of damaged 
genes potentially expands the field of DNA damage into the sphere of regulation of gene 
expression 45. While the interest in the role of epigenome in toxicity mechanisms is 
growing, the genotoxicity of chemicals has been more thoroughly studied and 
characterized, as evidenced by a systematic review of published studies of genotoxic 
carcinogens that investigated epigenetic endpoints 50. 
DNA methylation is another key epigenetic mechanism, regulating both gene 
expression and chromatin stability. DNA methylation studies have been recently 
combined with RNA-seq and ChIP-seq to identify the role of the changes in the 
methylome in disease pathogenesis 51. DNA methylation and genetic polymorphisms have 
important concomitant regulatory effects on transcription factor-driven gene expression 
52. Aberrant DNA methylation patterns due to exposure to environmental chemicals are 
also well-characterized. Exposure to benzene, metals, and traffic pollution are all 
examples of toxicants that can have an effect on DNA methylation 53-56. 
 
1.4 Environmental effects on the epigenome in the context of genetic variability 
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There is now overwhelming evidence that connects genetic variability and epigenetic 
marks and that chemical exposures can exert toxicity through epigenetic mechanisms; yet 
less is known about how the effects on the epigenome may vary in the population. 
Intriguing novel insights into linkages between genotoxic and epigenetic mechanisms of 
carcinogenesis, and the role of genetic variability among individuals have been provided 
by studies of a classical genotoxic carcinogen 1,3-butadiene. It is a genotoxic chemical 
with DNA damaging effects that vary among genetically distinct individuals. 1,3-
Butadiene is a major industrial chemical used in the production of synthetic rubbers and 
polymers. It is also a ubiquitous environmental contaminant that is found in cigarette 
smoke and automobile exhaust. IARC has classified 1,3-butadiene as a known human 
carcinogen 57. It is well established that the mechanism of carcinogenicity is due to 
butadiene’s reactive metabolites. These epoxides interact directly with DNA and form 
mutagenic DNA adducts. 1,3-Butadiene also elicits an epigenetic response, causing 
significant loss of global DNA methylation as well as a decrease in H3K9, H3K27, and 
H3K20 trimethylation in C57BL/6J mouse liver 58.  
Using a mouse population-based model it was shown that inter-individual (e.g., 
inter-strain) differences exist in both genotoxic and epigenotoxic effects of 1,3-butadiene 
exposure and that the chromatin remodeling response is at least one mechanism for the 
inter-strain differences in 1,3-butadiene-induced DNA damage 14. Specifically, it was 
shown that 1,3-butadiene alters bulk chromatin histone mark levels resulting in strain-
specific abundances of these marks. In particular, CAST/EiJ and C57BL/6J mice, two 
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genetically distinct strains, exhibited basal and treatment-induced differences in overall 
levels of these histone marks. 
 
1.5 Environmental effects on the epigenome in the context of sex-specific differences 
In general, sex-specific effects from environmental toxicant exposure are poorly 
characterized. This is supported by a recent systematic review of genotoxic human 
carcinogens that shows a deficiency in animal studies that examine sex-specific 
differences in epigenetic alterations caused by environmental agents50. Available studies 
focus on prenatal and in utero exposure to environmental chemicals59.  
 
1.6 Specific aims 
In this dissertation, three specific aims were developed to characterize inter-individual 
variability in DNA damage and epigenetic effects in response to chemical exposure. In 
specific aim 1, we evaluate population variability in genotoxicity and global epigenetic 
alterations by using a population-based mouse model. Specific aim 2 investigates sex-
specific differences in DNA damage and epigenetic modifications. Lastly, specific aim 3 
characterizes strain- and tissue-specific expression of microRNA, an additional epigenetic 
endpoint, in response to chemical exposure.   
 
Specific aim 1: To evaluate inter-individual differences in 1,3-butadiene-induced 
epigenetic alterations and DNA damage in a mouse population.  We hypothesized that 
DNA adducts and epigenetic effects will vary across strains. In this aim, we used a panel 
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of recombinant mouse lines from the Collaborative Cross resource. We evaluated DNA 
damage by measuring DNA adduct levels and epigenetic effects by analyzing histone 
modifications and DNA methylation.  
 
Specific aim 2: To investigate sex differences in genotoxic and epigenetic effects of 
1,3-butadiene.  This aim will test the hypothesis that exposure to 1,3-butadiene will result 
in sex-specific effects in DNA damage and epigenetic modifications. We used male and 
female C57BL/6J and CAST/EiJ mice to investigate epigenetic alterations by analyzing 
global histone modifications and DNA methylation changes. 
 
Specific Aim 3: To characterize microRNA expression profiles in response to 1,3-
butadiene exposure in mice. We hypothesize that 1,3-butadiene-induced microRNA 
expression varies between strains and tissues. To investigate strain-specific differences in 
microRNA expression in response to 1,3-butadiene exposure we will use male C57BL/6J 
and CAST/EiJ mice. We evaluated expression profiles in these two strains by Next 








2The text of this chapter is an Author’s Original Manuscript reprinted with permission from an article 
published by the American Chemical Society in Chemical Research in Toxicology on 16 April 2019, 
available online: https://doi.org/10.1021/acs.chemrestox.9b00035 
10 
CHAPTER II 
POPULATION-BASED ANALYSIS OF DNA DAMAGE AND EPIGENETIC 
EFFECTS OF 1,3-BUTADIENE IN THE MOUSE2 
 
2.1 Introduction 
Traditional toxicology studies in animals are conducted in a single strain and do 
not test for population variability, which is a critical need in human health risk 
assessment.9 A mouse population-based approach provides data on the variability in 
responses to chemicals at the population level.6 Indeed, studies that use multiple strains to 
model genetic diversity have successfully demonstrated the utility of the population-based 
approach for investigating inter-individual variability in toxicity and metabolism.60-62 
In the past decade, several genetically diverse mouse reference populations were 
created, including the Collaborative Cross.63, 64 The Collaborative Cross mouse genetic 
reference population is derived from eight founder strains and represents 90% of the 
genetic variation in laboratory mice.65 This recombinant inbred panel of strains aims to 
replicate the genetic heterogeneity of the human population66 and can be effectively used 
for quantitative trait loci (QTL) mapping because of their balanced allele frequencies.8 
Previous studies using Collaborative Cross mice have identified genetic determinants for 
disease susceptibility, biological pathways, and complex traits.67-70
An increasing number of toxicology studies are using the Collaborative Cross 
mouse population to evaluate inter-individual variability in susceptibility to toxicity.10, 71-




interactions; however, epigenetic determinants of inter-individual variability in responses 
to toxicants are yet to be explored.76 For example, while it is well documented that strain 
differences exist in both genotoxic and epigenetic effects of a known human carcinogen 
1,3-butadiene,14, 77, 78 few strains have been examined and the genetic determinants of 
these differences are yet to be mapped.  The importance of characterizing inter-individual 
variability for carcinogenic risks was highlighted by the National Academy of Sciences 1 
Science and Decisions report, which noted that current practices in cancer risk assessment 
largely neglect the presence of population variability in susceptibility to cancer.  Unlike 
for non-cancer effects, where notable progress has been made in addressing human 
variability both methodologically and in terms of data availability 60, 79, progress on 
addressing this gap for cancer effects has been lacking, partially due to lack of relevant 
data. 
 The goal of the present study was to investigate the extent and molecular drivers 
of inter-individual variability in DNA damage and global epigenetic effects of 1,3-
butadiene across three tissues, two of which are targets of 1,3-butadiene-induced 
carcinogenicity.  We hypothesized that tissue- and strain-specific epigenetic modifications 
affect inter-strain differences in DNA damage by 1,3-butadiene. We exposed mice from 
20 strains of Collaborative Cross to clean air or 635 ppm 1,3-butadiene by inhalation for 
2 weeks (6 hours/day, 5 days/week). Amount of N-7-(2,3,4-trihydroxybut-1-yl) guanine 
(THB-Gua) adducts, as well as changes in global cytosine DNA methylation and histone 
modifications were examined to evaluate inter-strain and tissue differences in both DNA 




the implications of these results for cancer risk assessment by calculating a chemical-
specific adjustment factor to quantitatively address inter-individual differences in cancer 
susceptibility. 
 
2.2 Materials and Methods 
Animals and exposures. Adult male mice (8-12 weeks old) from 20 Collaborative Cross 
strains were acquired from the University of North Carolina Systems Genetics Core 
(Chapel Hill, NC). Mice were fed an NTP 2000 wafer diet (Zeigler Brothers, Inc., 
Gardens, PA) and water ad libitum. The housing room was maintained on a 12-h light – 
and dark cycle.  Mice were allowed to acclimate for 14 days before study. Exposures 
consisted of filtered air or 1,3-butadiene 6/hr day, 5 days/week (Monday-Friday) for 2 
consecutive weeks as detailed elsewhere.58 One mouse from each strain was used for 
control or 1,3-butadiene exposed groups, a study design aimed to maximize the statistical 
power of the study by maximizing the number of strains tested.80 While sex-specific 
differences in epigenetic effects of 1,3-butadiene have been recently shown,81 this study 
was limited to the responses in male mice and further studies are needed to fully 
characterize sex-dependent genetic modifiers. Exposure concentration and protocol were 
selected based on the National Toxicology Program’s carcinogenesis studies with 1,3-
butadiene in mice.82 Concentrations of 1,3-butadiene in exposure chambers were 
monitored at the beginning and end of each daily exposure period using gas 
chromatography and the average concentration of 1,3-butadiene in the exposure chamber 




cessation of exposure. Mice were euthanized by exsanguination following deep isoflurane 
anesthesia. Tissues and blood were removed, snap-frozen in liquid nitrogen, and stored at 
-80ºC. All experimental procedures involving animals were reviewed and approved by the 
Institutional Animal Care and Use Committee at the University of North Carolina at 
Chapel Hill. 
Determination of N-7-(2,3,4-trihydroxybut-1-yl)-guanine (THB-Gua) adducts. 
Genomic DNA was isolated from flash-frozen liver, lung, and kidney using commercial 
kits (Qiagen, Germantown, MD) according to the manufacturer’s instructions. Levels of 
THB-Gua were measured as described elsewhere.83  
Methylated DNA immunoprecipitation qPCR analysis. Methylated DNA-
immunoprecipitation (MeDIP) was conducted in tissues from control and 1,3-butadiene 
exposed mice using the MethylMiner Methylated DNA Enrichment Kit (Invitrogen, 
Carlsbad, CA). The methylation status of long interspersed nuclear elements 1 (LINE-1) 
and short interspersed nuclear elements B1 (SINE B1) was evaluated by qPCR using 
immunoprecipitated DNA or input DNA. The primer sequences are listed in Supporting 
Information Table S1.  
Western blot analysis of histone modifications. The levels of trimethylation of histones 
H3 lysine 9 (H3K9me3), H3 lysine 27 (H3K27me3), and H4 lysine 20 (H4K20me3) and 
acetylation of histones H3 lysine 9 (H3K9ac), H3 lysine 27 (H3K27ac), and H4 lysine 16 
(H4K16ac) were evaluated by western immunoblotting as previously described 58 in 
control and 1,3-butadiene exposed mice.  The protein of interest was normalized to the 




each gel. Antibodies and their dilutions are listed in Supporting Information, Table S2. 
IRDye 800CW–labeled anti-rabbit secondary antibodies (LI-COR Biosciences, Lincoln, 
NE) was used for visualization. Fluorescence was measured using the Odyssey CLx 
Infrared Imager and the images quantified using ImageStudio 4.0 software (LI-COR 
Biosciences). Equal sample loading was confirmed by normalizing relative intensity of 
the protein of interest to the average relative intensity of two control samples loaded on 
each gel.   
Calculation of chemical-specific inter-individual variability factors based on inter-
strain variability. The National Academy of Sciences 1 proposed adding incorporation of 
a human variability factor in cancer risk assessment to characterize the degree to which 
more sensitive individuals may be at higher risk of developing cancer.  Here, we use inter-
strain variability as a surrogate for human variability 21, 60.  The degree of inter-strain 
variability in genotoxic and epigenetic effects of 1,3-butadiene was estimated by 
decomposing the total observed variance across Collaborative Cross strains into two 
components: intrinsic inter-strain heterogeneity and intra-strain variability (e.g., 
variability due to environmental factors and measurement error) as described in detail in 
Ref. 75 and is briefly summarized as follows. Because one sample from each Collaborative 
Cross strain was available, the intra-strain variability was estimated from previously 
reported data on variation in these parameters and tissues for C57BL/6J 14 or CAST/EiJ 84 
strains, as follows: 
σ2inter-strain = σ2total – σ2intra-strain 




σ2intra-strain= variance of log-transformed data from C57BL/6J or CAST/EiJ mice 
To quantitatively express the degree of inter-strain variability in the effects in each tissue, 
assuming a lognormal distribution for inter-individual variability, a human variability 
factor (HVF) was calculated as HVF= e z*σ, where z= Z statistics at the 95% cut-off, and 
σ represents the square root of inter-strain variance 1. The HVF calculated in this manner 
therefore theoretically represents the factor by which the cancer risk or slope factor is 
greater in the 95th percentile of the population as compared to that for the median 
individual. Higher percentiles, such as the 99th percentile used by U.S. EPA for 
trichloroethylene and dichloromethane 85, 86 can be derived by using larger values of z, but 
were not derived here given the sample size of ~20.    
Genome-wide quantitative trait locus (QTL) mapping. QTL mapping was conducted to 
identify potential loci driving differences in population variability in 1,3-butadiene-
induced DNA damage and epigenetic alterations. We used the gQTL web application 
v1.487 with the following settings: auto transformation, MegaMUGA Build 37, and 1000 
permutations. This approach uses genome scans with the classical Haley-Knott regression 
with a linear mixed model where the polygenic effect is captured in as random-effects. 
Statistical thresholds were determined by permutation analysis. Trait outliers were not 
removed. Phenotype data used for this analysis was DNA adduct levels and fold change 
for global epigenetic endpoints for each Collaborative Cross strain (Supporting 
Information, Table S3). A confidence interval based on the 1.5 LOD interval was used to 
mark the region likely containing the causative gene(s). This interval was compared to the 




created by inputting the chromosome region for a significant QTL to the University of 
California-Santa Cruz genome browser.  
Statistical Analyses. GraphPad Prism (La Jolla, CA) was used for statistical analysis of 
the phenotype data. Wilcoxon matched-pairs signed rank test was used to evaluate 
differences between control and 1,3-butadiene exposed samples. The F-test was used to 
compare variances. Significance was determined when p<0.05 for all tests performed. R 
software (version 3.4.3) was used to generate paired box plots (ggplot2 package) and 
correlation matrices (hmisc package).  
 
2.3 Results 
Population variability of 1,3-butadiene-induced DNA damage 
The metabolism of 1,3-butadiene results in formation of reactive epoxides which 
form a variety of DNA adducts, among which THB-Gua adducts are commonly used as a 
biomarker of 1,3-butadiene exposure.88, 89 Therefore in the present study we evaluated 
THB-Gua adduct levels in lung, liver and kidney of Collaborative Cross mice. Adducts 
were undetectable in mice exposed to filtered air (data not shown). Figure 1A shows that 
THB-Gua adducts were present in all tissues in 1,3-butadiene-exposed mice, but the 
number of adducts varied several-fold in each tissue. Among the tissues, the liver had the 
highest population mean of adduct levels followed by the kidney and lung. It is noteworthy 
that THB-Gua adduct levels positively correlate among all tissues with the strongest 




In concordance with previous reports, we observed inter-strain variability in 
adduct levels.14, 77, 81 For example, strains CC031, CC038 and CC061 had the highest 
THB-Gua adduct levels across tissues (Supporting Information, Figure S1). In contrast, 
strains CC016 and CC023 presented intermediate levels, and CC002 and CC039 had the 
lowest amount of THB-Gua adduct levels across tissues. Within each tissue, the range of 
THB-Gua adduct levels varied by two- to six-fold across the population tested. Although 
some strains showed consistent responses to 1,3-butadiene-exposure across tissues, there 
were also strains that demonstrated tissue-specific responses.  
Population variability in 1,3-butadiene-induced effects on global DNA methylation  
Exposure to 1,3-butadiene disrupts the epigenome status,58 an effect that is one of 
key characteristics of known human carcinogens.31 In order to examine changes in 
cytosine DNA methylation patterns in response to 1,3-butadiene exposure, we evaluated 
the methylation status of LINE-1 and SINE B1 retrotransposons, commonly used 
indicators of global methylation status.90 Figure 2 shows that there were no overall 
significant differences between control and 1,3-butadiene exposed mice across tissues. 
Previously reported DNA methylation data from a panel of inbred mouse strains showed 
that although inter-strain variability exists, the majority of strains did not present 
significant changes in the methylation status of LINE-1.14 In the lung, methylation levels 
of LINE-1 positively correlated with methylation levels of SINE B1. 
Even though there were no significant population 1,3-butadiene-induced effects 
on methylation of LINE-1 and SINE B1 elements, there was appreciable degree of inter-




CC038 showed increases in DNA methylation levels in response to 1,3-butadiene 
exposure. In contrast, in the same tissue, strains CC016, CC023, and CC028 showed loss 
of DNA methylation and strain CC068 had less than 10% change in methylation levels for 
both SINE B1 and LINE-1. Similar trends were observed in the liver and kidney. 
Interestingly, in the kidney, there was no strain with less than 10% change in DNA 
methylation levels. Our results are in concordance with previous multi-strain studies 
which identified 1,3-butadiene-induced strain-specific effects in DNA methylation 
patterns.14, 81  In the present study, strain responses also varied across tissues. For example, 
strains CC016 showed a loss of methylation in the lung and liver but an increase in 
methylation in the kidney. In previous studies, strain- and tissue-specific effects have also 
been identified. C57BL/6J mice demonstrated loss of methylation of SINE B1 in the liver 
whereas CAST/EiJ mice showed loss of methylation in the lung.81 
Population variability in 1,3-butadiene-induced effects on histone modifications  
 Exposure to chemicals can disrupt chromatin structure, a process that is tightly 
controlled by post-translational modifications of various histones.91, 92 Previous studies 
showed that 1,3-butadiene has effects on both histone modifications14, 58 and the chromatin 
landscape.77, 78 Figure 3 shows the effects on levels of H3K9me3, H3K27me3, 
H4K20me3, H3K9ac, H3K27ac, and H4K16ac across three tissues in control and 1,3-
butadiene exposed mice. There were significant decreases in trimethylation of H3K9 and 
acetylation of H3K27 in the lung in response to 1,3-butadiene at the population level. In 
contrast, there were significant increases in trimethylation of H4K20 in the liver and H3K9 




significant change in population mean in response to 1,3-butadiene exposure. While the 
overall population effects were less than 2-fold, inter-strain differences in chromatin 
responses were identified which is in concordance with previously reported results.14  
Correlation analysis of DNA damage and epigenetic phenotypes  
In order to investigate the associations among histone modifications, DNA 
methylation, and THB-Gua adduct levels, we performed rank (Spearman) correlation 
analyses. Figure 5A shows the global correlation matrix which includes phenotypes for all 
strains and tissues. This analysis shows that tissue-specific responses to 1,3-butadiene 
exposure are most evident, and in agreement with previous observations.77, 81 As noted 
previously, levels of THB-Gua were most similar in the lung and kidney and significantly 
correlated in all three organs. Among the epigenetic alterations evaluated, the effect of 
1,3-butadiene on cytosine DNA methylation and histone modifications was most 
prominent and concordant among the strains in the lung and liver, target organs for 1,3-
butadiene carcinogenicity (Figures 5B and 5C). In the lung, this was evidenced by a 
positive correlation between LINE-1 and SINE B1 methylation, and trimethylation and 
acetylation of histones (Figures 5B). In the liver, there were positive correlations between 
the trimethylation of H4K20 and H3K27 and between the trimethylation of H3K27 and 
H3K9 (Figure 5C), well-established marks of heterochromatin.93, 94  In contrast, 
correlations between epigenetic marks in the kidney, a non-target organ for 1,3-butadiene 
carcinogenicity, were less evident (Figure 5D). 
It should be noted, that liver was the only organ to show a significant correlation 




correlation between 1,3-butadiene-induced adduct levels and the extent SINE B1 
methylation at the population level (Figure 5C).  Similarly, at the individual mouse strain 
levels, CC001, CC061, and CC012 strains that exhibited the highest levels of THB-Gua 
were also characterized by lowest extent of SINE B1 methylation.  
Quantifying the variability in tissue-specific DNA damage and epigenetic effects of 1,3-
butadiene  
Our study collected quantitative data on population variability in DNA damage 
and epigenetic effects of 1,3-butadiene across various tissues, information that can be used 
to calculate chemical-specific human variability factors that pertain to its cancer hazard 
(Table 1). Specifically, we selected three representative phenotypes for quantifying the 
variability in tissue-specific DNA damage and epigenetic effects of 1,3-butadiene. THB-
Gua adducts were representative of genotoxic effects, methylation effects on LINE-1 of 
DNA methylation effects, and trimethylation of H3K9 of histone modification effects.  
These chemical-specific values represent the first attempt to incorporate chemical-specific 
data-informed susceptibility information beyond toxicokinetics in the cancer risk 
assessment of 1,3-butadiene.   
The variance in THB-Gua adducts was similar across lung, liver and kidney, 
leading to HVF values of less than a factor of 2. Similar variability was observed for the 
effects on H3K9 trimethylation. However, a large degree of variability in global DNA 
methylation, as measured by methylation of LINE-1, was observed, leading to HVF values 
of about 3 to 8.  Interestingly, the largest HVF value was for the kidney, which is not a 




lung and liver, these results suggest that susceptible individuals at the 95th percentile may 
be at up to 4 times higher risk based on these early events alone. 
QTL Mapping 
In order to identify genomic regions associated with inter-strain differences in 1,3-
butadiene-associated DNA damage and epigenetic effects, we performed QTL mapping 
using a model that considered each of the eight founder alleles separately87 with data on 
DNA adduct levels and log2 fold change values for epigenetic phenotypes (DNA 
methylation and histone modifications) from each strain and tissue. The QTL mapping 
provides genomic intervals that are statistically associated with trait variances. These 
intervals are typically marked by a confidence interval. Genome wide-significant (95% 
confidence) or suggestive (80-95% confidence) loci were identified in the lung (Figures 
6-8) and the boundaries and protein-coding genes in each locus are listed in Table 2. Genes 
residing within these intervals become candidates. By looking through genes residing 
within the intervals, those with credible linkages to histone modifications become high-
quality candidates for the causative drivers of variation in histone modification.  
H3K9me3 in the lung was significantly effected by 1,3-butadiene exposure at the 
population level and it also had one of the most prominent QTLs identified (Figure 6A). 
A 3.1 Mb locus (exceeding the suggestive genome-wide threshold of 85% confidence) for 
the effect of 1,3-butadiene on this histone mark is located on chromosome 6 (119.48-
122.59 Mb; 6qF1 region) and had a LOD score of 10.52 (p=2.89e-08). We found that 
PWK/PhJ and 129S1/SvlmJ founder strain alleles had most pronounced effects on this 




H3K9ac in the lung was not significantly effected by 1,3-butadiene exposure on 
the population level, but it had the most significant (exceeding genome-wide threshold of 
95% confidence) QTL (Figure 7A). An 8.2 Mb locus for the effect of 1,3-butadiene on 
this histone mark is located on chromosome 2 (33.32-41.50 Mb; 2qB region) and had a 
LOD score of 10.40 (p=3.75e-08). We observed that NOD/ShiLtJ founder allele had the 
most pronounced effect on this QTL (Figure 7B). This locus contains 49 protein-coding 
genes (Figure 7C, Table 2). 
H4K16ac in the lung was also not significantly effected by 1,3-butadiene exposure 
on the population level, but it had a suggestive QTL (exceeding genome-wide threshold 
of 85% confidence) (Figure 8A). A 0.54 Mb locus for the effect of 1,3-butadiene on this 
histone mark is located on chromosome 14 (33.42-33.96 Mb; 14qB region) and had a LOD 
score of 9.04 (p=6.17e-07). We observed that CAST/EiJ founder allele had the most 
pronounced effect on this QTL (Figure 8B). This locus contains 5 protein-coding genes 
(Figure 8C, Table 2). 
 
2.4 Discussion 
1,3-Butadiene, a known human and rodent carcinogen, has been used as a model 
genotoxic toxicant for investigating the mechanistic links between the genome, 
epigenome, and DNA damage.57, 77 1,3-Butadiene is an industrial chemical that is also a 
ubiquitous environmental contaminant and an occupational health hazard. Metabolism of 
1,3-butadiene results in formation of reactive epoxides which can form a number of 




carcinogenicity.88 Although 1,3-butadiene-associated DNA damage has been reported in 
all species and tissues tested, only lung, liver and lymphoid organs are the target tissues 
for tumorigenesis in the mouse.95 In humans, hemoglobin adducts and urinary butadiene-
mercapturic acids serve as biomarkers for 1,3-butadiene exposure.88, 96 Lymphocytes 
obtained from 1,3-butadiene exposed factory workers demonstrated genetic damage such 
as sister-chromatid exchanges and chromosomal aberrations.97 Occupational human 
exposure to 1,3-butadiene is associated with an increase incidence of leukemia.57  
In addition to genotoxicity, exposure to 1,3-butadiene results in epigenetic effects, 
including effects of histones,58, 81, 84 chromatin remodeling,77, 78 and alterations in cytosine 
DNA methylation.14, 58 Strain-dependent tissue-specific epigenetic variability in these 
effects was demonstrated using inbred mouse strains.14, 77, 78, 81 The effects on chromatin 
states and cytosine DNA methylation have been identified as a potential mechanism for 
the tissue-specific carcinogenicity of 1,3-butadiene.50, 98 This suggests that variation in 
epigenetic alterations could influence the inter-individual susceptibility to 1,3-butadiene 
genotoxicity. In this study, using a much larger mouse population, a compendium of 
Collaborative Cross mouse strains, we demonstrate that 1,3-butadiene-induced THB-Gua 
adducts and epigenetic alterations in lung, liver, and kidney of exposed mice greatly vary 
among organs and strains. Butadiene is carcinogenic in mice at doses as low as 6.25 ppm 
and it has been tested in doses of up to 8,000 ppm;99 thus, our selection of exposure 
concentration that is well within the range of carcinogenic doses is based on both prior 
studies by others,83, 100 and our own work demonstrating robust and strain-specific 




tissue-specific levels of THB-Gua adducts were highly correlated. These data are of 
significance because while THB-Gua is widely used as a biomarker of effect in studies of 
1,3-butadiene, it was not known how well tissue extrapolations can be made.88   
It is also well-recognized that epigenetic alterations are as important for the 
carcinogenic process as those that are characterized as genotoxicity31, 50 and that cross-talk 
between these two key characteristics of known human carcinogens exists.101 Some 
epigenetic changes may drive the development of cancer, while others may be 
accompanying epigenetic events. Therefore, it is important to identify the epigenetic 
changes that are driving the development of the chemical-induced carcinogenic process. 
In this respect, a marked decrease in trimethylation of histone H3K9 in the lung, as well 
as demethylation of SINE B1 in the liver that tightly correlated with the formation of THB-
Gua adducts in the liver and other tissues, are of potential significance. 
With respect to the population-based effects on DNA methylation, we note that 
our data in 20 CC lines demonstrates discordant strain-specific effects and the lack of the 
overall effect of 1,3-butadiene on global changes in DNA methylation. This observation 
is concordant with that reported in 7 inbred mouse lines14, and further reinforces the need 
to employ population-based models in toxicological studies to account for population-
wide differences in effects.6, 60 Furthermore, the lack of population-wide effects does not 
negate a potential role for DNA methylation effects in relation to the overall strain-specific 
mechanisms. For example, we note that SINE retrotransposons are some of the most 
abundant transposable elements dispersed throughout the mammalian genome. It is 




retrotransposons, respectively.102 Activation of expression of these transposable elements 
may lead to genetic instability, and cytosine DNA methylation plays a fundamental role 
in their transcriptional silencing and protecting of genome.103  The results of numerous 
studies have demonstrated that prolonged exposure to genotoxic chemical carcinogens 
may result in a loss of SINE methylation and their transcriptional activation.14, 81, 84  In 
light of this, an inverse correlation between the levels of THB-Gua adducts and SINE B1 
methylation in the liver found in this study provides a mechanistic insight for 1,3-
butadiene induced carcinogenesis. Still, future studies on the locus-specific methylation 
patterns are needed to fully address the role of DNA methylation in susceptibility to 
butadiene-associated carcinogenesis, especially in light of recent reports that tissue 
variation in cancer risk correlates with the degree of aberrant CpG island DNA 
methylation in normal cells.104  
Even though the population size of the Collaborative Cross mice used in this study 
was relatively small in terms of mapping needs, haplotype-associated mapping yielded 
several candidate loci and genes for the observed epigenetic effects of 1,3-butadiene. 
Complex long-term exposure studies in multiple strains are difficult to conduct in large 
populations, a known challenge to the adoption of the population-wide studies in 
toxicology.61 Still, candidate genes that are identified through genomic mapping studies 
can afford additional strength to the mechanistic linkages between exposures and effects. 
In this study, we aimed to determine whether inter-strain variation in genes that have been 
linked to chromatin dynamics may explain the inter-individual variability in 1,3-




Histone H3K9me3 plays a central role in the formation of heterochromatin and the 
maintenance of genomic stability and chromatin integrity.105 Therefore, a loss of histone 
H3K9 trimethylation may compromise genomic stability and integrity, a key event in the 
carcinogenic process.30 Indeed, several reports demonstrated a link between 
demethylation of histone H3K9me3 and carcinogenesis.106, 107 In the lung, we identified a 
QTL associated with the effects on histone H3K9me3. The Collaborative Cross population 
demonstrated a significant decrease in H3K9me3 in response to 1,3-butadiene exposure 
with a two and a half fold difference across strains. In this genomic region, we identified 
a lysine-specific demethylase gene, KDM5A (also known as JARID1A or RBP2). Although 
it is well-established that KDM5A removes methyl groups from di- and trimethylated 
H3K4, there is evidence of chromatin crosstalk, which refers to histone methyltransferases 
binding to non-target substrates. KDM5A contains three plant homeodomains (PHD) 
fingers which are considered chromatin recruitment modules that bind methyl-lysine 
residues. In yeast, PHD3 has been shown to bind to histone H3K9me3.108 KDM5C and 
LID, homologs of KDM5A, have also demonstrated affinity toward H3K9me3.109, 110  
We also identified a significant QTL for histone H4K16ac in the lung. H4K16ac 
is involved with genomic stability and chromatin organization.111 A loss of histone 
H4K16ac has been proposed as a marker of carcinogenesis.112 Although there were no 
significant changes in the population mean of H4K16ac in response to 1,3-butadiene 
exposure, it is important to note that a fourfold difference between lowest and highest 
levels among strains. We identified MAPK8 (also known as JNK1) as a candidate gene 




that targets H4K16.113 Previously, SIRT1 expression was shown to be upregulated across 
tissues in 1,3-butadiene exposed C57BL6/J mice, which may contribute to sensitivity to 
1,3-butadiene effects.84 
 Similar to histone H4K16ac, we identified a suggestive QTL that may be 
associated with 1,3-butadiene-mediated effects on histone H3K9ac in the lung. There were 
no significant changes in H3K9ac identified at the population level; however, among 
strains, there was a threefold difference in 1,3-butadiene-induced effects on this histone 
mark. There are two candidate genes related to chromatin biology in the QTL identified. 
The first candidate gene, CRB2, is a recruitment protein that binds to H4K20me2 which 
is critical for repair of double strand breaks 114. Loss of methylation reduces CRB2 
recruitment which consequently decreases cell survival after genotoxic exposure 115.  The 
second gene of potential interest is NEK6, a kinase linked to mitotic regulation 116. In 
human cells, NEK6 has demonstrated the ability to phosphorylate histones 1 and 3 117.  
In addition to using the population-based data for further elucidation of the tissue-
specific epigenetic effects of 1,3-butadiene, these data can be used to quantify the 
variability and enable the greater translation and the application in health risk assessment. 
Thus, we derived chemical-specific human variability factors for the effects of 1,3-
butadiene on DNA damage and epigenetic markers in three tissues. We reason that these 
quantitative estimates can be considered in addressing human variability in future cancer 
assessments of 1,3-butadiene.  Interestingly, we found the 1,3-butadiene-specific 
adjustment factors for DNA damage effects based on our data to be modest, less than a 




was for this endpoint in the kidney, which is not a target tissue of 1,3-butadiene 
carcinogenicity.  This result needs to be considered in light of the fact that the overall 
population-level change in kidney methylation is small (1.19-fold relative to control), 
suggesting that the “typical” individual may be minimally affected with only a small 
proportion of individuals more highly affected. Because genotoxicity is well accepted as 
a key event in the mechanism of 1,3-butadiene carcinogenicity, the HVF based on adducts 
probably represents a lower bound on the degree of variability in cancer susceptibility; 
however, questions remain as to how directly variation in epigenetic effects correlate with 
variation in cancer risks 50. Additionally, it is possible that variation in downstream 
carcinogenic processes will also contribute to overall variation in cancer risk.  
Nonetheless, our results represent a key milestone in the use of a population-based model 
to characterize cancer susceptibility experimentally and provide data that may be directly 
useable in future re-evaluations of cancer risks of 1,3-butadiene exposure.   
 Overall, we conclude that by using the Collaborative Cross mouse model, we were 
able to investigate population variability in epigenetic and genotoxic effects in response 
to a model genotoxic chemical 1,3-butadiene. We identified tissue-specific epigenetic 
modifications which provide mechanistic insight to carcinogenesis in 1,3-butadiene target 
organs. Furthermore, we observed strain-specific epigenetic alterations which may play a 
role in individual susceptibility to DNA damage. Genetic mapping identified four 
candidate genes that may be driving underlying differences in chromatin remodeling for 
H3K9me3, H3K9ac, and H4K16ac. Furthermore, we calculated chemical-specific 




quantitative estimates that may be used in evaluation of inter-individual differences in 
cancer susceptibility for this chemical. Together, these findings demonstrate that 
population-based studies provide a model for uncovering the underlying mechanisms 
through which genetic variability and lay a foundation for future investigations into the 
degree and mechanisms of susceptibility to carcinogenic risks, addressing a critical gap in 
existing cancer risk assessments. 
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Table 2.1 Quantitation of inter-strain variability in genotoxic and epigenetic effects 
of 1,3-butadiene. 
 




relative to control) 
H3K9me3 
(Fold-change  
relative to control) 
 Lung Liver Kidney Lung Liver Kidney Lung Liver Kidney 
GM 135 175 136 0.902 0.950 1.19 0.879 1.08 1.12 
GSD 1.45 1.23 1.29 2.42 1.81 3.50 1.28 1.33 1.20 
σ2total 0.152 0.044 0.088 1.02 0.592 1.91 0.072 0.097 0.051 
σ2intra-
strain 
0.012 0.002 0.024 0.240 0.240 0.341 0.011 0.014 0.018 
σ2inter-
strain 
0.139 0.042 0.064 0.781 0.352 1.57 0.060 0.083 0.033 
HVF 1.85 1.40 1.52 4.28 2.65 7.87 1.50 1.61 1.35 
 
GM=geometric mean; GSD= geometric standard deviation; σ
2
total= variance of log-
transformed data from this study; σ
2







intra-strain; HVF = Chemical-specific human 













Table 2.2 Quantitative Trait Loci mapping using log2 fold change values for each 
phenotype identified loci on chromosomes 2, 6 and 14. Genes found in these regions 






















Fbxl14, Erc1, Rad52, Wnk1, Ninj2, B4galnt3, 
Ccdc77, Kdm5a, II17ra, Tmem121b, Hdhd5, 
Cecr2, Slc25a18, Atp6v1e1, Bcl2l13, Bid, Mical3, 
Pex26, Tuba8, Usp18, Slc6a13, Slc6a12, lqsec3, 
A2m, Mug1, Mug2, Klrg1, M6pr, Phc1, Rimklb, 







Ralgps1, Zbtb34, Zbtb43, Lmx1b, Mvb12b, Pbx3, 
Mapkap1, Gapvd1, Hspa5, Rabepk, Fbxw2, Psmd5, 
Cutal, Phf19, Traf1, Hc, Cntrl, Rab14, Gsn, Stom, 
Ggta1, Dab2ip, Ttll11, Ndufa8, Morn5, Lhx6, 
Rbm18, Mrrf, Ptgs1, Pdcl, Rc3h2, Zbtb26, Zbtb6, 
Rabgap1, Gpr21, Strbp, Crb2, Dennd1a, Lhx2, 
Nek6, Psmb7, Nr5a1, Nr6a1, Wdr38, Rpl35, 













Figure 2.1 Population variability in genotoxicity of 1,3-butadiene across mouse 
tissues. Strain variability in levels of THB-Gua adducts in lung, liver, and kidney of mice 
exposed to 625 ppm of 1,3-butadiene for 2 weeks. The box shows the 1st and 3rd quartile 
ranges, the horizontal line represents the median, and the whiskers represent the min and 
max values. Each circle represents data for a CC strain. (B-D) Pairwise inter-tissue 
correlation in THB-Gua adducts in the populations of CC strains is shown as scatter plots. 
Trend lines and corresponding   (Spearman correlation) and p values are shown in each 







Figure 2.2 Population variability in global DNA methylation associated with 
exposure to 1,3-butadiene across mouse tissues. The results are presented as box and 
whisker plots for control (left) and 1,3-butadiene exposed mice (right) for LINE-1 (A) and 
SINEB1 (B) in the lung-left panel, liver-middle panel, and kidney-right panel. The box 
shows the 1st and 3rd quartile ranges and the whiskers represent the standard errors of the 
population mean. Each circle represents a mouse in the control or 1,3-butadiene exposed 
group. Lines connect the data for animals of the same strain. The dashed gray line 








Figure 2.3 Population variability in histone modifications associated with exposure 
to 1,3-butadiene across mouse tissues. The results are presented as box and whisker plots 
for control (left box plot in each panel, triangles) and 1,3-butadiene exposed mice (right 
box plot in each panel, circles). The box shows the 1st and 3rd quartile ranges and the 
whiskers represent the min and max values. Results are expressed as the relative intensity 
for each sample (see Methods for normalization procedure). Asterisks (*) denote 









Figure 2.4 Effect levels on histone modifications with significant population 
variability associated with exposure to 1,3-butadiene across mouse tissues. Histone 
marks (H3K9me3-top panel, H4K20me3-middle, H3K27ac-bottom) that exhibited 
significant differences between population means of control and 1,3-butadiene exposed 
mice are shown. Each circle represents the log2 of fold change value for each strain and 
tissue (lung-left panel, liver-middle, kidney-right). Asterisks (*) denote significant 









Figure 2.5 Correlation of genotoxic and epigenetic effects of 1,3-butadiene across 
mouse strains and tissues.  Pairwise rank (Spearman) correlation analysis results where 
values used for DNA methylation and histone modifications were log2 (fold change 
relative to control)-transformed. (A) A correlation matrix of the phenotypes in all tissues 
of 20 CC strains. (B-D) Correlation matrices within each tissue. The x-axis labels (left to 
right) are identical to the y-axis labels (top to bottom). Each circle represents a significant 










Figure 2.6 QTL mapping of H3K9me3. Values used for H3K9me3 were log2 (fold 
change relative to control)-transformed. Panel (A) shows the logarithmic odds ratio (LOD) 
scores across chromosomes 1 through X. The green, blue, and red lines represent the 
permutation-based significance thresholds of 85%, 90%, and 95% respectively (n=1000 
permutations). Panel (B) shows the effects of the CC founder strain alleles on chromosome 
6 (top) and a zoom-in on the chromosome region with a corresponding significant LOD 
score. Panel (C) shows the UCSC genes that are located on chromosome 6 [6qF1] in the 










Figure 2.7 QTL mapping of H3K9ac. Values used for H3K9ac were log2 (fold change 
relative to control)-transformed. Panel (A) shows the logarithmic odds ratio (LOD) scores 
across chromosomes 1 through X. The green, blue, and red lines represent the 
permutation-based significance thresholds of 85%, 90%, and 95% respectively (n=1000 
permutations). Panel (B) shows the effects of the CC founder strain alleles on chromosome 
2 (top) and a zoom-in on the chromosome region with a corresponding significant LOD 
score. Panel (C) shows the UCSC genes that are located on chromosome 2 [2qB] in the 









Figure 2.8 QTL mapping of H4K16ac. Values used for H4K16ac were log2 (fold change 
relative to control)-transformed. Panel (A) shows the logarithmic odds ratio (LOD) scores 
across chromosomes 1 through X. The green, and blue lines represent the permutation-
based significance thresholds of 85% and 90% respectively (n=1000 permutations). Panel 
(B) shows the effects of the CC founder strain alleles on chromosome 14 (top) and a zoom-
in on the chromosome region with a corresponding significant LOD score. Panel (C) 
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SEX-SPECIFIC DIFFERENCES IN GENOTOXIC AND EPIGENETIC EFFECTS OF 
1,3-BUTADIENE AMONG MOUSE TISSUES3 
 
3.1 Introduction
Accumulating evidence suggests that environmental chemicals may alter the epigenome 
by disrupting cytosine DNA methylation patterns, chromatin structure and expression of 
noncoding RNAs 50, 91, 118. Epigenetic reprogramming has been linked to genomic 
instability, a hallmark of cancer 30, and induction of epigenetic alterations is one of key 
mechanistic characteristics of known human carcinogens 31. Epigenetic alterations may be 
a result of DNA damage or non-genotoxic effects of chemicals 45.  However, even though 
there is an increasing interest in investigating the relationships between the states of the 
epigenome and chemical-induced adverse health effects 50, 119, few studies have considered 
sex-specific differences in epigenetic effects of chemicals, most of these were focused on 
prenatal or early life exposures 59, 120, 121.    
It is well acknowledged that sex is an important biological variable that now is 
required to be included into research designs, analyses, and reporting in vertebrate animal 
and human studies 122. Therefore, we aimed to study a chemical with well-known sex-
specific differences in adverse health effects and determine whether its effects on 
epigenetic phenotypes are also sex-dependent. Specifically, we selected 1,3-butadiene, an 





In humans, exposure to 1,3-butadiene is associated with cancer in the haematolymphatic 
organs 124. In mice, liver, lung, and lymphoid tissues are the primary sites of 1,3-butadiene-
induced carcinogenesis 125
Sex-specific differences in 1,3-butadiene-induced genotoxicity and 
carcinogenicity have been established in rodents and humans. Significant differences 
between male and female mice were reported in the levels of 1,3-butadiene DNA damage 
in the liver 126.  Sex-specific differences have also been identified in the occurrence of 1,3-
butadiene-induced Hprt gene mutations, with female rodents exhibiting a greater 
susceptibility 127. In human studies, female factory workers exposed to 1,3-butadiene had 
lower globin adduct levels when compared to  male workers, but not other markers of 
genotoxicity, possibly because of the sex-specific differences in toxicokinetics of 1,3-
butadiene 128.  With respect to tumor development, tumor sites also vary between males 
and females in studies of rats and mice 125, 129. Furthermore, female mice form tumors at 
lower concentrations of 1,3-butadiene than male mice, further implicating sex-specific 
mechanisms as drivers of susceptibility to 1,3-butadiene-induced carcinogenesis 125. 
Epigenetic effects of 1,3-butadiene are well established and have been studied in multiple 
tissues of male mice 14, 77, 78. These studies demonstrated that there are organ- and strain-
dependent effects. Variability in 1,3-butadiene-induced chromatin alterations represents 
one possible mechanism for strain-specific differences in DNA damage 77, 78. Two inbred 
mouse strains, C57BL/6J and CAST/EiJ, have been extensively studied based on their 
sensitivity and resistance to 1,3-butadiene-induced DNA damage 14. In addition, inter-




dysfunction using the Collaborative Cross mouse population model 73. With respect to 
carcinogenesis-related genetic and epigenetic effects of 1,3-butadiene in mice, it was 
found that while exposure-induced DNA adducts are present in lung, liver, and kidney 77, 
epigenetic alterations 84 and tumor formation are restricted to the liver and lung 82, 125. 
Tissue-specific epigenetic effects may provide mechanistic clues with respect to why 
certain organs are resistant to carcinogenesis even though they harbor appreciable genetic 
damage from 1,3-butadiene. In this study, we investigated sex-specific differences in DNA 
damage and epigenetic effects in response to 1,3-butadiene exposure in various organs in 
two inbred mouse strains. Overall, our results demonstrate that there are sex-specific 
differences in epigenetic modifications among mouse tissues and that these differences 
may play a role in cancer susceptibility in response to 1,3-butadiene exposures. 
 
3.2 Methods 
Animals and exposures 
Male and female CAST/EiJ and C57BL/6J mice (Jackson Laboratory, Bar Harbor, 
ME; 9-13 weeks old) were housed in sterilized cages in a temperature-controlled (24°C) 
room with a 12/12-h light/dark cycle. Mice had ad libitum access to purified water and 
NIH-31 pelleted diet (Purina Mills, Gray Summit, MO). These strains were selected based 
on previous results which indicated that C57BL/6J male mice are more susceptible to 1,3-
butadiene-induced DNA damage and epigenetic effects compared to CAST/EiJ male 
mice, which are considered more resistant 14. Mice were allowed to acclimatize for 2 




Subsequently mice were exposed to filtered air or 425 ppm 1,3-butadiene 6 hr/day, 5 
days/week (Monday-Friday) for two consecutive weeks, a study dosing and duration based 
on previous studies of 1,3-butadiene genotoxicity88. The average concentration of 1,3-
butadiene in the exposure chamber in this study was 425.8+/-162.0 ppm. An in life portion 
of the study and tissue collection were previously described 84 and were approved by the 
Institutional Animal Care and Use Committee at the University of North Carolina at 
Chapel Hill. 
Determination of N7-guanine adducts and bis-N7-guanine crosslinks 
Genomic DNA was isolated from flash-frozen liver, lung and kidney using a 
Qiagen DNeasy Blood & Tissue Kit (Qiagen, Germantown, MD) according to the 
manufacturer’s instructions. Levels of N-7-(2,3,4-trihydroxybut-1-yl)-guanine (THB-
Gua) and 1,4-bis-(guan-7-yl)-2,3-butanediol crosslinks (bis-N7G-BD) in DNA were 
evaluated as described elsewhere 126, 130.  
Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) 
Total RNA was extracted with an RNeasy kit (Qiagen) from flash-frozen samples 
of the liver, lung and kidney. The High Capacity cDNA Reverse Transcriptase Kit 
(Applied Biosystems, Carlsbad, CA) was used to synthesize cDNA. Treatment-induced 
effects on gene expression for Mpg, Mgmt, Xrcc1, Dnmt1, Dnmt3a, and Dnmt3b were 
assessed by qRT-PCR. Detailed information on mouse-specific primer sequences and 
catalogue numbers is provided in Supplemental Table 1. Reactions were performed with 
two to four replicates in a 96-well plate using the 7900HT Fast Real-Time PCR system 





DNA methylation of repetitive sequences 
The McrBC-methylation sensitive quantitative PCR (qPCR) assay was used to 
determine the methylation status of short interspersed nucleotide elements  B1 and B2 
(SINEB1 and SINEB2)  retrotransposons and minor and major satellites repetitive 
sequences in liver, lung, and kidney, as described  in Martens et al 131. Genomic DNA was 
digested overnight with the restriction enzyme McrBC (New England Bio Labs, Beverly, 
MA) and subsequently analyzed with qPCR on the 7900 Real Time PCR System (Applied 
Biosystems).  
Western blot analysis of histone modifications 
Total histones were extracted as described elsewhere 132. Briefly, tissue samples 
were lysed with lysis buffer, incubated for one hour on ice, and centrifuged at 14,000×g 
for 10 minutes at 4°C. The supernatant was removed and mixed with 10 volumes of 
acetone for an overnight incubation. The precipitates were air-dried then dissolved in 
water. The levels of trimethylation of histones H3 lysine 9 (H3K9me3), H3 lysine 27 
(H3K27me3), and H4 lysine 20 (H4K20me3)  were evaluated by western immunoblotting 
using corresponding antibodies (Upstate, Charlottesville, VA) in the livers and kidneys of 
control and 1,3-butadiene-exposed mice as described elsewhere 132. Equal sample loading 
was confirmed by immunostaining against total H3 and H4.  
Statistical Analyses 
Results are presented as mean +/- SD. GraphPad Prism was used for statistical 




Spearman correlation coefficients were used to evaluate correlations between phenotypes. 
Significance was determined when p<0.05 for all tests performed.  
 
3.3 Results 
Sex-specific differences in 1,3-butadiene-induced DNA damage and repair  
Metabolism of 1,3-butadiene yields a number of DNA-reactive moieties that form 
DNA adducts and cross-links in cultured cell, mice, rats, and humans 88, 129. In the present 
study, we investigated THB-Gua adducts and bis-N7G crosslinks as markers of 1,3-
butadiene-induced genotoxicity across several tissues in male and female mice. Figure 1 
shows that THB-Gua adducts and bis-N7G crosslinks were present in all 1,3-butadiene-
exposed mice. We include previously reported C57BL/6J male mice bis-N7G crosslinks 
results 84 for comparison. In C57BL/6J male mice, adduct levels were similar to those 
previously reported at a comparable 1,3-butadiene dose 84. Both guanine monoadducts and 
DNA-DNA crosslinks were 5-20% lower in female mice than in male mice across all 
tissues in C57BL/6J strain. Our data are also concordant with major differences in the 
susceptibility to 1,3-butadiene-induced DNA damage between CAST/EiJ and C57BL/6J 
male mice 14. Specifically, CAST/EiJ mice had three- to four-fold lower adduct and 
crosslink levels compared to C57BL/6J mice. No differences between male and female 
mice in adduct and crosslink levels were observed in CAST/EiJ strain. Among all tissues, 
in both strains and sexes, the lung had the highest levels of DNA damage, followed by the 




To further investigate sex-specific differences in DNA damage, we evaluated the 
expression of DNA repair genes that are involved in the base excision repair pathway 
(Mpg and Xrcc1) and removal of O6-methyl guanine (Mgmt). Figure 2 shows sex-specific 
changes in DNA repair enzyme expression across liver, lung, and kidney. In C57BL/6J 
mice, there was a marked increase in expression of Mgmt in 1,3-butadiene-exposed female 
mice in the kidney, while in the liver, both Mgmt and Mpg expression was significantly 
decreased after exposure. In CAST/EiJ mice, Mpg was induced in the liver of female mice 
and Xrcc1 was significantly decreased in the liver of female mice and the lung of male 
mice.  
Sex-specific alterations in 1,3-butadiene-induced cytosine DNA methylation patterns 
Increasing evidence suggests that disruption of cytosine DNA methylation patterns 
can play a role in disease 133. Repetitive elements that are a major component of the 
genome 131 are usually methylated in somatic cells 134 and can serve as indicators of global 
DNA methylation status 90. To investigate sex-specific cytosine DNA methylation 
changes in response to 1,3-butadiene exposure, the methylation status of SINEB1 and 
SINEB2 retrotransposons, as well as major and minor satellites, was assessed in control 
and 1,3-butadiene-treated mice across tissues. It is known that 1,3-butadiene exposure 
resulted in strain-dependent changes in DNA methylation patterns, where CAST/EiJ 
remained unaffected while C57BL/6J male mice exhibited DNA hypomethylation in the 
liver 14. Previously reported DNA methylation data from male C57BL/6J mice 84 was used 
here to compare to the new data for C57BL/6J female mice and male and female CAST/EiJ 




retrotransposons and major and minor satellites in response to 1,3-butadiene exposure. In 
male C57BL/6J mice, exposure to 1,3-butadiene was associated with loss of cytosine DNA 
methylation in the liver, whereas in female mice significant loss of cytosine DNA 
methylation was observed in the lung.  No treatment-related cytosine DNA methylation 
changes were found in the kidney in male and female C57BL/6J mice. In contrast, 
exposure of CAST/EiJ mice to 1,3-butadiene resulted in 2- to 4-fold increase in repetitive 
element cytosine DNA methylation in the liver and lung in female mice, whereas only 
minor and sporadic DNA hypomethylation changes were found in the liver, lung, and 
kidney of male CAST/EiJ mice.  
To provide mechanistic insight into 1,3-butadiene-associated sex-specific 
differences in DNA methylation, the expression of DNA methyltransferase genes were 
investigated. Figure 4 shows that overall there were few effects on expression of Dnmt1, 
Dnmt3a, or Dnmt3b in 1,3-butadiene-exposed mice in the liver, lung, and kidney.  
Specifically, in C57BL/6J mice, there was a decrease in expression in Dnmt1 and Dnmt3a 
in the liver in both male and female mice, albeit this effect was significant only in male 
mice. In CAST/EiJ mice, a significant decrease in expression of Dnmt3a was observed in 
the liver in both male and female mice. In the lungs, a significant decrease in expression 
of Dnmt3a and Dnmt3b was observed in male mice only.  
Sex-specific differences in 1,3-butadiene-induced histone modifications  
Disruption of the chromatin structure has been associated with chemical carcinogen 
exposure 14, 91, 135. In the present study, histone modifications that are related to chromatin 




H3K9me3, H3K27me3, and H4K20me3 in the liver and kidney. In male C57BL/6J mice, 
effects of 1,3-butadiene on post-translational histone modifications were concordant with 
previously reported findings, which showed a significant increase in trimethylation of 
histones H3K9, H3K27 and H4K20 in the kidney 84. In female C57BL/6J mice, significant 
increases in trimethylation of H3K27 and H4K20 were also observed in the kidney. A 
significant increase in H3K27ac was only observed in the liver of C57BL/6J male mice. 
In CAST/EiJ strain, 1,3-butadiene-exposed male mice exhibited significant increases in 
histone H3K9, H3K27, and H4K20 trimethylation in the liver, concordant with previous 
report 14. In contrast, there was a significant decrease in trimethylation of histone H4K20 
in the kidney of male CAST/EiJ mice and decrease in trimethylation of histones H3K9 
and H3K27 in in the kidney of female mice.  We also evaluated histone methyltransferase 
genes; however, there were no significant changes (data not shown). 
 
3.4 Discussion 
This study used 1,3-butadiene as a model genotoxic environmental chemical to 
investigate sex-specific differences in genotoxic and epigenetic effects. Exposure to 1,3-
butadiene has been previously associated with the formation of DNA monoadducts and 
DNA-DNA crosslinks 136, as well as changes in DNA methylation and chromatin structure 
14. Our results indicate that 1,3-butadiene-induced DNA damage and epigenome 
disruption are sex-dependent. In addition, these observed sex-specific 1,3-butadiene-




It is well established that exposure to 1,3-butadiene results in the formation of 
DNA monoadducts and interstrand crosslinks as supported by animal and human studies 
88. Similar to previous findings, we observed that 1,3-butadiene-induced DNA damage 
was highest in the lung, followed by the kidney, and liver. Our results also are in accord 
with previously identified inter-strain differences in DNA adduct formation between male 
CAST/EiJ and C57BL/6J mice 14, 77. We found significant sex-specific differences in both 
monoadducts and interstrand crosslinks only in the lung of C57BL/6J mice. Sex-specific 
differences in 1,3-butadiene genotoxicity are well-documented. Female rats and mice have 
twice the DNA-DNA crosslink formation in the liver compared to male rats and mice 126. 
Additionally, female rats and mice have a higher incidence of Hprt mutations 127. Human 
molecular epidemiology studies reported similar or lower globin adduct levels in 1,3-
butadiene-exposed female factory workers compared to male workers 128. Our results also 
report levels of DNA damage in C57BL/6J mice that are concordant with findings in 
humans. Sex-specific differences in THB-G adduct levels have not been previously 
reported; however, in the present study we observed significant differences between 
C57BL/6J male and female mice 88. The interplay between strain and sex may influence 
susceptibility to DNA damage. Strain- and sex-specific molecular events including 
upregulation of DNA repair enzymes and chromatin remodeling could be responsible for 
the observed significant differences in DNA adduct and crosslink formation between 
C57BL/6J male and female mice.  
Investigating the expression of DNA repair enzymes may explain the variability 




exposure to 1,3-butadiene on DNA repair gene expression in the base and nucleotide 
excision pathways was rather muted overall. However, we observed up to an 8-fold 
induction of Mgmt in kidneys of female mice of C57BL/6J strain, which may be a result 
of their sensitivity to the adverse effects of 1,3-butadiene in comparison to other mouse 
strains 14. C57BL/6J male mice also demonstrate an increase in expression in the lung, 
which could be in response to the higher incidence of DNA adduct and crosslink 
formation. While 1,3-butadiene is not known to form O6-alkylguanine adducts, DNA 
cross-links at the O6 position of guanine generated by butadiene present in tobacco smoke 
have been reported 138. In addition, human MGMT could play a role in repair of these 
crosslinks 139. Sex-specific differences in DNA repair gene expression have been 
identified in acute low-dose exposure to radiation, which induced a significant 
upregulation of Mgmt in female mice 140. In addition, up-regulation of Mgmt, as observed 
in C57BL/6J female mice in the kidney, has been associated with resistance to 
carcinogenesis 141. 
Chemical exposure can also result in disruption of global DNA methylation 33. 
Sex-dependent changes in DNA methylation have been reported. For example, exposure 
to radiation and arsenic led to loss of methylation, however it was more evident in females 
compared to males 142, 143. Exposure to 1,3-butadiene is associated with strain- and tissue-
specific changes in DNA methylation, with varying degrees of cytosine DNA 
hypomethylation or no effect 14, 84.  
In the present study we found a sex- and strain-dependent hypomethylation of 




C57BL/6J mice, two target organs for 1,3-butadiene-induced carcinogenesis in mice.  In 
contrast, no treatment-related cytosine DNA methylation changes were found in the 
kidney, a non-target organ, in male and female C57BL/6J mice, even though the level of 
1,3-butadiene-induced genotoxic alterations in the kidney of C57BL/6J mice was greater 
than in the liver.  These findings provide a strong support of the importance of epigenetic 
alterations, in addition to genotoxic alterations, in the mechanism of chemical 
carcinogenesis.  Additionally, the results of the present study corresponded to growing 
evidence of the ability of genotoxic carcinogens to induce non-genotoxic genomic 
alterations, e.g. transcriptomic and epigenomic, in target organ only.  Specifically, it has 
been demonstrated that in vivo or in vitro exposure to the model genotoxic carcinogen 
benzo[a]pyrene resulted in the induction of both genotoxic and non-genotoxic alterations 
in target, but not in non-target organs 144, 145. 
In order to uncover the underlying mechanisms of 1,3-butadiene-induced DNA 
methylation effects, we investigated the expression of DNA methyltransferases, which 
control the status of cytosine DNA methylation. Surprisingly, we found only slight down-
regulation of Dnmt1 and Dnmt3a in the livers of male C57BL/6J, indicating that inhibition 
of DNA methyltransferases is not the main factor that caused cytosine DNA 
hypomethylation in 1,3-butadiene-carcinogenesis target organs in C57BL/6J mice. It is 
well-known that the accurate status of the DNA methylome is maintained by the following 
factors; proper functioning of DNA methylation and demethylation pathways, DNA 
integrity, and one-carbon metabolism, which provides methyl groups for all cellular 




methyltransferases, nor 1,3-butadiene-induced genotoxic alterations, except in the lung of 
female mice, could explain the loss of cytosine DNA methylation in the liver and lung of 
C57BL/6J mice.  This indicates that disruption of other molecular pathways such as 
mitochondrial dysfunction 73 and 1,3-butadiene-induced oxidative stress 147, 148, known 
factors that cause cytosine DNA hypomethylation 149, or alterations in one-carbon 
metabolism and tricarboxylic acid cycle, may cause loss of DNA methylation in the liver 
and lung of C57BL/6J mice. 
 Another interesting finding in our study is increased cytosine DNA methylation 
in the lung and liver in 1,3-butadiene-exposed CAST/EiJ female mice and no methylation 
changes in these organs in male mice. This may be attributed, at least in part, to 
substantially lower levels of 1,3-butadiene-induced DNA adducts and crosslinks in 
CAST/EiJ mice as compared to C57BL/6J mice. Although hypermethylation has been 
implicated in carcinogenesis 150, evidence suggests that increased levels of cytosine DNA 
methylation at repetitive elements could also provide protection against DNA damage 151. 
Hypermethylation has also been proposed as a protective epigenetic mechanism against 
repeat expansion-associated pathologies 134, 152.  An additional mechanism that may 
prevent the loss of cytosine DNA methylation in target organs is formation of compact 
chromatin in response to chemical exposure.  Indeed, we observed an increase in 
trimethylation of histones H3K9, H3K27, and H4K20 in the liver of male CAST/EiJ mice. 
This finding reinforces previously reported observations with exposure to a higher dose 




In summary, this study focused on identifying sex-specific differences in DNA 
damage and global epigenetics. Our results demonstrate that although DNA damage was 
present in all tissues, changes in DNA methylation and histone modification patterns 
varied between strains, sexes, and tissues. The present study demonstrates the existence 
of sex-specific differences in response to 1,3-butadiene exposure and provides strong 
evidence to support NIH policy on including both sexes in experimental animal studies. 
Additional follow up experiments that evaluate the chromatin landscape and gene 
expression profiles through ATAC-seq and RNA-seq may provide additional insight to 
sex-dependent toxicant induced responses. Furthermore, miRNA are also key epigenetic 
regulators that have been shown to have sex-dependent expression. Investigating the 
interplay between the miRNome and epigenetic machinery could provide further 
mechanistic insights.   
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Figure 3.1 Levels of THB-Gua-butadiene adducts (left panel) and bis-N7G-butadiene 
crosslinks (right panel) in tissues from female (gray bars) and male (black bars) mice 
exposed to 425 ppm of 1,3-butadiene. Data are presented as mean +/-SD. Asterisk, pound, 
and ampersand (*, #, and &) denote significant (p<0.05) differences in the levels of 
adducts or crosslinks between C57BL/6J or CAST/EiJ male and female mice, C57BL/6J 










Figure 3.2 Effects of 1,3-butadiene exposure on the expression of DNA repair genes 
across strains and tissues (liver – top panel, lung – middle panel, kidney – bottom panel). 
White bars are controls, gray bars are treated females and black bars are treated males.  
Results are presented as the average fold change relative to the control values for each 
strain and sex. Data are expressed as mean +/-SD. Asterisks (*) denote significant (p<0.05) 
differences from corresponding strain and sex controls. Missing samples (male kidney, 






Figure 3.3 Effects of 1,3-butadiene exposure on the extent in DNA methylation across 
strains and tissues (liver – top panel, lung – middle panel, kidney – bottom panel). White 
bars are controls, gray bars are treated females, and black bars are treated males.  The 
results are presented as fold change relative to the control values for each strain and sex. 
Data are presented as mean +/-SD. Asterisks (*) denote significant (p<0.05) difference 










Figure 3.4 Effects of 1,3-butadiene exposure on the expression of DNA methyltransferase 
genes across strains and tissues (liver – top panel, lung – middle panel, kidney – bottom 
panel). White bars are controls, gray bars are treated females and black bars are treated 
males.  The results are presented as fold change relative to the control values for each 
strain and sex. Data are presented as mean +/-SD. Asterisks (*) denote significant (p<0.05) 







Figure 3.5 Effects of 1,3-butadiene exposure on histone trimethylation and acetylation 
across strains and tissues (liver – top panel, kidney – bottom panel). All histone levels 
were evaluated by immunostaining using specific antibodies against trimethylated or 
acetylated histones. Equal sample loading was confirmed by immunostaining against total 
H3 or H4. Densitometry analysis of the immunostaining results is shown as percent change 
in methylation levels relative to control after correction for the total histone levels in each 
sample. White bars are controls, gray bars are treated females and black bars are treated 
males.  The results are presented as fold change relative to the control values for each 
strain and sex in mouse tissues. Data are presented as mean +/-SD. Asterisks (*) denote 







CHAPTER IV  
MICRORNA AS REGULATORS OF 1,3-BUTADIENE-INDUCED STRAIN- AND 
TISSUE-SPECIFIC EFFECTS IN MICE 
 
4.1 Introduction 
microRNA (miRNA) are short, noncoding RNA that act as post-transcriptional 
repressors through translational inhibition or degradation of mRNA. miRNA can regulate 
numerous genes or one gene can be targeted by multiple miRNA.  In addition, miRNA are 
involved in diverse biological processes such as apoptosis, cell proliferation, and 
development153-155. Furthermore, aberrant expression of miRNA has been implicated in 
various diseases including carcinogenesis156.  
In recent years, research focusing on miRNA in the field of toxicology has rapidly 
expanded. Accumulating evidence shows dysregulation of miRNA expression occurs in 
response to environmental toxicants such as heavy metals, air pollution, and cigarette 
smoke156-158. In humans and rodents, miRNA have also been identified as biomarkers of 
chemical exposure and tissue-specific injury159. However, the underlying mechanisms of 
miRNA expression in chemical-induced carcinogenesis is still undergoing investigation.  
Exposure to 1,3-butadiene a model genotoxic chemical, results in DNA damage 
and epigenetic effects. In previous studies, we have observed 1,3-butadiene-induced 
strain-specific DNA damage and epigenetic alterations14, 58. Population-based models 
have demonstrated inter-strain variability in the chromatin remodeling response which 




tissue-specific epigenetic modifications in response to 1,3-butadiene exposure have been 
observed84. Alterations in global DNA methylation and histone modifications associated 
with genomic instability were observed in lung and liver which are target organs of 1,3-
butadiene carcinogenesis but not in the kidney, a non-target organ.  
In this study, we expanded upon our previous work which focused on 1,3-
butadiene-induced global histone modifications and DNA methylation changes by 
investigating miRNA expression in response to 1,3-butadiene exposure. We hypothesized 
that miRNA regulate strain- and tissue-dependent transcriptional and epigenetic responses 
to 1,3-butadiene exposure in CAST/EiJ and C57BL/6J mice. These mice were exposed to 
clean air or 625ppm 1,3-butadiene (6 hr/day, 5 days/week) for 2 weeks. Distinct miRNA 
expression profiles were observed between strains and tissues as a result of 1,3-butadiene 
exposure. In addition, we identified miRNA as candidate master regulators of 1,3-
butadiene-altered gene expression. Our results indicate that miRNA may influence strain- 
and tissue-dependent chemical-induced carcinogenesis. 
 
4.2 Materials and Methods 
Animals and exposures 
The in vivo portion of this study and tissue collection was detailed in Chappell et al78. 1,3-
butadiene exposure results in tumorigenesis at doses from 6.25ppm to 8000ppm99. In brief, 
male CAST/EiJ and C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME; 9-13 weeks 
old) were exposed to filtered air or 1,3-butadiene for 6h/day, 5 days/week, Monday-




average concentration of 1,3-butadiene in the exposure chamber was 593 +/- 61 ppm. 
Animals were treated humanely and with regard for alleviation of suffering. The 
procedures were approved by the Institutional Animal Care and Use Committee at the 
University of North Carolina at Chapel Hill.  
 
RNA and small RNA sequencing, data processing, and differential analysis 
Total RNA was isolated from flash-frozen tissues with the Qiagen miRNeasy Kit. RNA 
and small RNA libraries were prepared for sequencing as described in Chappell et al78. 
Libraries were sequenced on the Illumina Hiseq 2500. miRNAs were annotated and 
quantified using the bioinformatics pipeline miRquant 2.0 as described by Kanke et al 161. 
RNA-seq data was processed as described in Chappell et al78. Differentially expressed 
mRNAs and miRNAs were identified by using the DESeq2 version 1.24.0 in R version 
3.6162. A minimum threshold of 10 reads in at least five mice from one strain was required.  
 
miRNA pathway enrichment analysis 
In order to determine the pathways targeted by miRNA that were significantly enriched in 
response to 1,3-butadiene exposure, differentially expressed miRNA (adjp<0.1) identified 
in each tissue from each strain were uploaded into DIANA-miRPath163. Analyses were 
conducted under the following settings: Mouse, Tarbase, and genes union. Results were 







Identification of miRNA regulatory hubs 
Candidate miRNA regulatory hubs of 1,3-butadiene-induced expression were identified 
by Monte Carlo simulation as previously described78, 164. In this analysis, we used 
differentially expressed genes (padj <0.1) in 1,3-butadiene-exposed mice relative to 
control mice for each strain and tissue. Gene sets were separated out and run by expression 
directionality. Predicted miRNA targets were required to be conserved only in mouse. 
Significant candidate miRNA (p-value <0.1) that were predicted by miRhub were cross-
referenced with significantly differentially expressed miRNA in 1,3-butadiene-exposed 
mice relative to control mice for each strain and tissue.  Our final list of candidate miRNA 
was selected based on the directionality of miRNA and mRNA expression.  
 
4.3 Results 
In this study, we characterized strain- and tissue-specific miRNA expression in response 
to 1,3-butadiene, a model genotoxic carcinogen. In order to investigate the role of miRNA 
in chemical-induced carcinogenesis and potentially identify biomarkers of exposure, we 
used two inbred strains with established inter-strain differences in 1,3-butadiene-induced 
DNA damage and epigenetic effects.  
 
Strain-specific miRNA expression at baseline across strains and tissues 
In order to investigate if baseline miRNA expression profiles influence responses to 1,3-




CAST/EiJ and C57BL/6J control mice which were exposed to clean air. Figure 1 shows 
the average reads per million mapped for each miRNA there was expressed in both strains 
at baseline. We identified 263 miRNA in lung, 172 miRNA in liver, and 176 miRNA in 
kidney that were differentially expressed between control CAST/EiJ and C57BL/6J (padj 
<0.1). We identified miRNA that are recognized as biomarkers for tissue-specific toxicity 
and disease; 3 in the lung, 3 in the liver, and 5 in the kidney (Figure 1). Figure 2A shows 
differentially expressed miRNA identified from the baseline inter-strain comparison 
(Supplemental Table 1). There were 22 differentially expressed miRNA common among 
lung, liver, and kidney. The lung had the highest number of tissue-specific differentially 
expressed miRNA. The liver and kidney were similar with 83 and 89 differentially 
expressed miRNA. Next, we used differentially expressed miRNA and their validated 
mRNA targets to identify biological networks present at baseline between strains and 
across tissues. Figure 2B shows the pathways (p-value <0.05) that were significantly 
enriched in CAST/EiJ and C57BL/6J control mice (Supplemental Table 2). Tissue-
specific pathways are listed in Figure 2C. Each tissue presented pathways that were 
involved in general biological processes as well as pathways specific to carcinogenesis. 
The liver had the most tissue-specific pathways followed by lung, and kidney.  
 
Strain-specific miRNA expression in response to 1,3-butadiene across strains and 
tissues 
We investigated if 1,3-butadiene-induced miRNA expression profiles differed between 




detected from control verse 1,3-butadiene exposure contrasts for each strain and tissue. 
There were more differentially expressed miRNA in 1,3-butadiene-exposed C57BL/6J 
mice to 1,3-butadiene-exposed CAST/EiJ across tissues. In both strains, the lung had the 
most differentially expressed miRNA followed by the kidney and liver. There were no 
differentially expressed miRNA identified in the liver of CAST/EiJ. Differentially 
expressed isomiRs presented similar findings. Figure 3A shows the common and unique 
miRNA across strains and tissues in response to 1,3-butadiene exposure (Supplemental 
Table 3). The lung and kidney of 1,3-butadiene-exposed C57BL/6J mice had the highest 
number of tissue-specific differentially expressed miRNA. There were 75 differentially 
expressed miRNA in common between the lung and kidney in 1,3-butadiene-exposed 
C57BL/6J mice compared to 1,3-butadiene exposed CAST/EiJ mice which had zero 
differentially expressed miRNA in common. Between 1,3-butadiene exposed CAST/EiJ 
and C57BL/6J lung, there were 4 differentially expressed miRNA in common and between 
1,3-butadiene CAST/EiJ and C57BL/6J kidney, there was 1 differentially expressed 
miRNA in common.  
Next, we explored miRNA targeted pathways in response to 1,3-butadiene 
exposure. Figure 3B shows enriched pathways targeted by significant miRNA for 1,3-
butadiene-exposed CAST/EiJ and C57BL/6J mice in lung and kidney. There was twofold 
more strain-specific pathways identified for C57BL/6J mice in the lung and eightfold more 
in the kidney compared to CAST/EiJ mice (Supplemental Table 4). Figure 3C shows 
the pathways that were common between CAST/EiJ and C57BL/6J mice in lung. We 




chemical carcinogenesis and glutathione metabolism that were relevant to 1,3-butadiene 
exposure. We also detected pathways related to chemical exposure in the kidney in 
CAST/EiJ which are shown in Figure 3D.    
 
Candidate drivers of 1,3-butadiene-induced differential gene expression  
We identified 9 candidate miRNA regulatory hubs across strains and tissues (Table 4.1).  
 
4.4 Discussion 
1,3-Butadiene is a known rodent and human carcinogen that is both an occupational and 
environmental health hazard. Genotoxicity is an established mechanism of 1,3-butadiene 
carcinogenicity; however, it does not explain the tissue-specific tumor development 
observed in mice. Our previous work demonstrated strain- and tissue-specific alterations 
in epigenetic effects in response to 1,3-butadiene exposure which may contribute to tissue-
specific toxicity. In the present study, we aimed to extend our findings by evaluating 
miRNA expression. miRNA represent another epigenetic mechanism for regulating gene 
expression and have been implicated in carcinogenesis. Our results show that 1,3-
butadiene-induced miRNA expression in C57BL/6J and CAST/EiJ mice occurs in a strain- 
and tissue-dependent manner and may influence the development of carcinogenicity in the 
target organs of 1,3-butadiene carcinogenicity.  
We observed marked strain-specific effects on miRNA expression between 
C57BL/6J and CAST/EiJ mice.  The effect of 1,3-butadiene had a minor effect on miRNA 




concordant with 1,3-butadiene-induced mRNA expression which was previously 
evaluated in CAST/EiJ and C57BL/6J mice77.  Although there is sufficient evidence that 
miRNA expression is affected by toxicant exposure, few studies have addressed inter-
strain differences in miRNA expression in response to chemical exposure. Inter-strain 
differences were reported in miRNA expression in the liver of mice that were fed a methyl-
deficient diet in order to induce nonalcoholic steatohepatitis165. These strain-specific 
differences were implicated in the susceptibility to disease development. Two studies used 
a panel of inbred mouse strains to evaluate population variability in miRNA expression. 
First, exposure to dust mite allergen resulted in variability in miRNA expression between 
strains in the lung166. A second study identified inter-strain differences in plasma miRNA 
expression along with a significant correlation with miRNA expression and strain-specific 
liver injury as a result of cholate deficient diet167.  
With respect to tissue-specific effects on miRNA expression, we observed 
similarities between C57BL/6J and CAST/EiJ mice across tissues. In both strains, the most 
differentially expressed miRNA were identified in the lung, followed by the kidney. 
Interestingly, there was almost no effect of 1,3-butadiene exposure on miRNA expression 
in the liver of both strains. Observed differentially expressed miRNA may serve as 
potential biomarkers of 1,3-butadiene exposure. However, they will not serve as markers 
of 1,3-butadiene-induced DNA damage which was present in all tissues. Exploring 
additional markers for 1,3-butaidene-induced DNA damage may offer further insight. 
Increasing our knowledge of miRNA in response to chemical exposure will help with 




 In this study, we explored an additional epigenetic mechanism, miRNA in 
response to 1,3-butadiene exposure. We observed distinct miRNA expression profiles 
across strains and tissues. Our results reinforce previously described 1,3-butadiene-
induced strain- and tissue-specific epigenetic effects. In addition, our findings emphasize 
the importance of considering genetic differences in experimental animal studies. 
Interestingly, we identified miRNA as candidate master regulators of 1,3-butadiene-
induced gene expression. Collectively these findings indicate that miRNA may influence 

















Table 4.1 The number of differentially expressed miRNA and isomiRs in response to 
1,3-butadiene exposure for each strain and tissue.   
Strain Tissue Total DE genes (padj<0.1) miRNA isomiR 
C57BL/6J Lung 210 142 68 
Liver 0 0 0 
Kidney 142 94 48 
CAST/EiJ Lung 27 15 12 
Liver 1 1 0 




Table 4.2 Candidate miRNA identified as master regulators of mRNA expression.   
  
Strain Tissue miRNA family miRhub p-value 
C57BL/6J Lung miR-126-5p 0.009980 
miR-142-5p 0.073852 
Liver miR-324-5p 0.007984 
miR-10abc/10a-5p 0.009980 


















Figure 4.1 Baseline miRNA expression across strains and tissues. Scatterplots 
represent the average reads per million mapped miRNAs (RPMM) for each miRNA 
expressed in both control C57BL/6J and CAST/EiJ mice across tissues. Circles are colored 








Figure 4.2 Pathway analysis of baseline miRNA expression across strains and tissues. 
A. Venn diagrams represent differentially expressed miRNA identified from the baseline 
inter-strain comparison for each tissue (padj < 0.1). Numbers within each sector of circles 
represent either unique or common differentially expressed miRNA. B. Tissue-specific 
pathways (p-value <0.05) using the differentially expressed tissue-specific miRNA (padj 
<0.1). C. Table shows the tissue-specific pathways. The p-value is the enrichment value 
derived from the DIANA-miRPATH analysis using the DIANA-tarbase (experimentally 
validated). Second and third column show the number of genes targeted by miRNA within 






Figure 4.3 Strain-specific miRNA expression in response to 1,3-butadiene across 
strains and tissues. A. Venn diagrams represent differentially expressed miRNA in 
response to 1,3-butadiene exposure for each strain and tissue (padj < 0.1). Numbers within 
each sector of circles represent either unique or common differentially expressed miRNA. 
B. Venn diagrams show strain-specific pathways in response to 1,3-butadiene exposure. 
Panel C shows 1,3-butadiene-induced pathways that are shared between C57BL/6J and 
CAST mice in the lung. Panel D shows 1,3-butadiene-induced pathways that were 








DNA damage occurs as a result of exposure to environmental and occupational 
chemicals and can lead to cancer. Toxicant exposure can also alter the state of the 
epigenome, creating genome instability which is an enabling characteristic of cancer30. 
Epigenetic modifications are recognized as being equally important in the development of 
carcinogenesis as genotoxic events such as DNA damage31, 50. In addition, it is well 
established that crosstalk between these two types of molecular perturbations occurs 
during the carcinogenic process101.  Epigenetic events may facilitate carcinogenesis or 
they may occur as a result of genotoxicity. Therefore, it is critical to understand the role 
of epigenetic modifications in chemical-induced carcinogenesis. In this dissertation, we 
address genotoxicity and epigenetic events in response to chemical exposure in order to 
understand the interplay between these molecular initiating events. Furthermore, we 
sought to understand mechanisms and biological drivers for inter-individual susceptibility 
to chemical exposure.   
In specific aim 1, we investigated inter-individual variability in the effects of 1,3-
butadiene exposure using the Collaborative Cross population-based mouse model. We 
were the first to use this population-wide approach to characterize epigenetic determinants 
of population variability in response to chemical exposure. We observed marked inter-
strain differences in DNA damage and global epigenetic modifications which emphasizes 




population variability in response to chemical exposure. Importantly, this study also 
identified tissue-specific epigenetic alterations, providing mechanistic insight for 1,3-
butadiene carcinogenesis in target organs. Although there were no significant population 
changes in global DNA methylation changes, we identified an inverse correlation between 
THB-Gua adduct levels and SINE B1 methylation in the liver. Evidence shows that 
exposure to genotoxic chemicals can result in altered DNA methylation leading to 
transcriptional activation14, 81, 84.  In addition, we identified four candidate genes related to 
chromatin remodeling that may act as drivers of inter-strain variability in the modifications 
of H3K9me3, H3K9ac, and H4K16ac in response to 1,3-butadiene exposure. Furthermore, 
our study quantified the inter-individual variability in phenotypes allowing for application 
in human health risk assessment. This approach addresses a critical gap in cancer risk 
assessment. Overall, our work in specific aim 1 demonstrates how the Collaborative Cross 
mouse population can be used to explore mechanistic linkages as well as quantify the 
degree of inter-individual variability in tissue-specific effects that are relevant to toxicant-
induced carcinogenesis.  
 In specific aim 2, we evaluated sex-differences in DNA damage and epigenetic 
effects in response to 1,3-butadiene exposure. Sex-specific differences in 1,3-butadiene-
induced genotoxicity and carcinogenicity are well established; however, it remained 
unknown whether 1,3-butadiene-associated epigenetic alterations are also sex-dependent. 
Importantly, our results indicate that 1,3-butadiene-induced DNA damage and epigenome 
disruption is sex dependent. Furthermore, we also observed that sex-specific effects occur 




interplay between strain and sex-specific molecular initiating events. Specifically, DNA 
repair enzymes and changes in chromatin structure could be driving significant differences 
in DNA damage between C57BL/6J male and female mice. In addition, our findings 
suggest that strain and sex-specific effects of 1,3-butadiene on the epigenome may 
contribute to the known differences in cancer susceptibility. Specific aim 2 also 
emphasizes the importance of supporting the NIH policy on including both sexes in 
experimental animal studies.  
In specific aim 3, we expanded our investigation of epigenetic alterations in 
response to chemical exposure to include miRNA, an additional epigenetic endpoint. We 
observed marked differences in 1,3-butadiene-induced miRNA expression between strains 
and tissues. We also identified several differentially expressed miRNA in the lung of 
C57BL/6J mice which may explain strain- and tissue-specific sensitivity to 1,3-butadiene 
exposure in comparison to CAST/EiJ mice. Our results support another epigenetic mark 
that acts in strain- and tissue-specific manner. These findings are also important for the 
application of miRNA as biomarkers of exposure to human carcinogens.  The results of 
this study indicate that miRNA may mediate strain- and tissue-dependent variability of 
1,3-butadiene-induced epigenetic effects and potentially greater tissue susceptibility to 
carcinogenesis.  
Overall, this dissertation emphasizes the importance of characterizing epigenetic 
marks as a result of exposure to a human carcinogen. Each specific aim contributed to a 
better understanding of the molecular events associated with chemical exposure. Our 




butadiene exposure occur in a strain- and tissue-specific manner. We also show the 
importance of investigating sex-specific chemical-induced epigenetic and genotoxic 
effects. In addition, we showed the utility of a population-based mouse model to explore 
inter-individual variability in epigenetic alterations and DNA damage. Together, our 
findings increase the knowledge of toxicant-induced epigenetic effects in order to 
effectively incorporate epigenetic endpoints into human health risk assessment.  
 
5.2 Limitations 
Several limitations can be identified with our study designs. We conducted 
exposures at one concentration of 1,3-butadiene and one time point for each animal study. 
Additional information may be obtained from investigating the relationship between 
multiple time points, concentrations, and epigenetic endpoints. Furthermore, the sample 
size of our animal studies were limited by the size of the exposure chamber. In Chapter II, 
in order to maximize the number of Collaborative Cross strains used in the experiment, 
we used a sample size of one mouse per strain. Lastly, in our 2 week exposure design, 
mice do not develop tumors in response to 1,3-butadiene exposure. Therefore, to validate 
that strain- and tissue-specific epigenetic alterations may influence individual and target 
organ susceptibility to carcinogenesis, long term studies should be conducted.  
The studies in this dissertation could be enhanced by incorporating several 
additional experiments. First, conducting ATAC-seq, RNA-seq, and small RNA-seq could 
help evaluate the chromatin landscape, transcriptome, and miRnome and provide 




(Chapter III). Global epigenetic experiments are informative however including next 
generation sequencing technologies would allow for the integration of ATAC-seq and 
RNA-seq data to identify potential gene regulatory regions. Second, we could investigate 
the protein levels of genes of interest identified in our studies. In Chapter II, we identified 
four candidate genes as drivers of inter-individual variability of 1,3-butadiene-induced 
chromatin structure alterations. In Chapter III, we evaluated the gene expression of DNA 
repair enzymes and DNA methyltransferases. Finally, in Chapter IV, we identified target 
genes of miRNA who may act as regulators of 1,3-butadiene-induced mRNA expression. 
Therefore, in these studies we could evaluate the levels of protein for each gene to better 
understand these genes and their relevant biological processes.   
 
5.3 Future directions 
 We have shown that exposure to 1,3-butadiene, a model genotoxic chemical, 
results in DNA damage and epigenetic effects. In addition, we have demonstrated that 
epigenetic and chromatin effects may be a key driver of tissue-specific susceptibility to 
genotoxic effects of butadiene 58, 77, 84. However, we have yet to explore the persistence of 
epigenetic modifications after cessation of exposure to an environmental toxicant such as 
1,3-butadiene. Although the persistence of effects from exposure to environmental 
chemicals are of great interest, they are not well characterized. Few studies address the 
lasting effects chemical exposure has on both the epigenome and the transcriptome. The 




chemical exposures could be transient yet other studies show that there could be 
irreversible aberrant gene expression168-170. 
In future studies, we plan to evaluate the persistence of 1,3-butadiene-induced 
epigenetic alterations including miRNA expression in target and non-target tissues. In 
addition, we will also assess genotoxicity and transcriptional alterations. Male CAST/EiJ 
and C57BL/6J mice will be exposed to 1,3-butadiene for 1 or 2 weeks followed by a 
“washout” of 1 or 2 weeks of clean air. We will evaluate the persistence of 1,3-butadiene-
induced epigenetic effects by evaluating global histone modifications and changes in 
global DNA methylation. In addition, we will also use ATAC-sequencing to look at 
changes in the chromatin landscape. Transcriptional effects will be assessed by RNA-
sequencing and miRNA expression will be evaluated by small RNA sequencing.  
Our work in mice has also shown that inter-individual differences in both 
genotoxic and epigenetic effects of butadiene exist and can be modeled using a mouse 
population approach 14, 78. While these data from an in vivo mouse model are important, 
they require species extrapolation and also were conducted using concentrations far 
exceeding human exposures. In the future, we aim to transition our previous work from a 
mouse population model to an in vitro human population model and our overall objective 
will be to investigate population variability in epigenetic alterations and DNA damage in 
response to butadiene using a human in vitro population-based model.  
Previous analysis from our lab shows that with up to 100 individual cell lines it is 
possible to accurately predict whether the extent of inter-individual variability in response 




human lymphoblast and PSC models will be up to 100. Lymphoblasts cell lines will be 
selected from our library of 1100+ cell lines from 9 populations of European, African, and 
Asian admixed ancestry, population used in several previous studies 172-175. The human 
PSC lines will be ones previously used by Cellular Dynamics International to derive iCell 
and myCell cardiomyocytes 176. A concentration-response of butadiene metabolites (1,2-
epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol) will be evaluated and 
include human exposure-relevant doses 177. We will evaluate cell viability 172, as well as 
DNA damage and DNA repair kinetics with the high-throughput comet chip assay 178. 
Next, we will select 10 PSC and 10 human lymphoblast cell lines based on the variability 
in responses to DNA damage and cytotoxicity and will evaluate N-7-(2,3,4-trihydroxybut-
1-yl)-guanine (THB-Gua) adducts, gene expression 179, 180 and chromatin remodeling 181. 
Overall this work will evaluate the use of a novel human in vitro population-based model, 
which could serve as a valuable tool for high-throughput chemical screening to assess 
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Figure S2.1. Strain variability in genotoxicity of 1,3-butadiene across mouse tissues. 
Inter-strain differences in levels of THB-Gua adducts in lung, liver, and kidney of mice 
exposed to 625 ppm of 1,3-butadiene for 2 weeks. Each red circle represents DNA adduct 













Table S2.1. Primers used for methylated DNA immunoprecipitation qPCR analysis. 
Gene Name Primer Sequence 
SINEB1 Forward 5’GTGGCGCACGCCTTTAATC3’ 
Reverse 5’GACAGGGTTTCTCTGTGTAG3’ 





Table S2.2. Primary antibodies used for western blotting. 
Target modification Dilution Catalog Number Supplier 
H3K9me3 1:1000 ab8898 Abcam 
H3K27me3 1:1000 ab6002 Abcam 
H4K20me3 1:1000 ab9053 Abcam 
H3K9ac 1:1000 ab10812 Abcam 
H3K27ac 1:1000 ab4729 Abcam 






Table S2.3. Phenotype data used for genome-wide quantitative trait loci (QTL) mapping. 
Data are expressed as the number of adducts per 108 nucleotides (for DNA adduct data) 





















Supplemental Table 3.1. Selected primers and their assay numbers from Applied 
Biosystems. 
Gene Gene Expression Assay Number 
Gusb Mm00446953_m1 
Dnmt1 Mm00599763_m1 
Dnmt3a Mm00432881_m1 
Dnmt3b Mm01240113_m1 
Suv39h1 Mm00468952_m1 
Suv420h2 Mm00525366_m1 
Ezh2 Mm00468464_m1 
Xrcc1 Mm00494222_m1 
Mgmt Mm00485014_m1 
Mpg Mm00447872_m1 
 
 
 
